Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ZyVersa Therapeutics, Inc. - Common Stock (NQ:ZVSA)

0.3113 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.3113
Bid (Size)	0.2835 (43)
Ask (Size)	0.2890 (10)
Prev. Close	0.3113
Today's Range	0.3113 - 0.3113
52wk Range	0.3113 - 1.950
Shares Outstanding	8,095,921
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Nasdaq's Delisting Wave: Navigating the Shifting Tides of Public Markets

September 24, 2025

The Nasdaq Stock Market has seen a notable increase in delistings over recent periods, signaling a recalibration of public market standards and a challenging environment for certain companies. This...

Via MarketMinute

ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes

September 10, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

Performance

YTD	-71.4%	-71.4%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	-40.5%	-40.5%
1 Year	-74.9%	-74.9%

More News

ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression

September 03, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Highlights Data Demonstrating a Critical Need for Therapies to Address Kidney Lipotoxicity to Alleviate Diabetic Kidney Disease (DKD) and Its Progression

August 14, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones

August 13, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress

July 21, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

July 18, 2025

Via Chartmill

Which stocks are moving after the closing bell on Thursday? ↗

July 17, 2025

Via Chartmill

Top movers analysis one hour before the close of the markets on 2025-07-16: top gainers and losers in today's session. ↗

July 16, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 09, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

July 09, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 09, 2025

Via Benzinga

Top movers in Tuesday's session ↗

July 08, 2025

Via Chartmill

Most active stocks in Tuesday's session ↗

July 08, 2025

Via Chartmill

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? ↗

July 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 08, 2025

Via Benzinga

What's going on in today's session ↗

July 08, 2025

Via Chartmill

ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds

July 08, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

Tuesday's pre-market session: top gainers and losers ↗

July 08, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 08, 2025

Via Benzinga

ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis

July 08, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator™ VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)

June 26, 2025

From ZyVersa Therapeutics

Via GlobeNewswire

Why Worthington Steel Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

June 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 25, 2025

Via Benzinga

Frequently Asked Questions

Is ZyVersa Therapeutics, Inc. - Common Stock publicly traded?

Yes, ZyVersa Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does ZyVersa Therapeutics, Inc. - Common Stock trade on?

ZyVersa Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ZyVersa Therapeutics, Inc. - Common Stock?

The ticker symbol for ZyVersa Therapeutics, Inc. - Common Stock is ZVSA on the Nasdaq Stock Market

What is the current price of ZyVersa Therapeutics, Inc. - Common Stock?

The current price of ZyVersa Therapeutics, Inc. - Common Stock is 0.3113

When was ZyVersa Therapeutics, Inc. - Common Stock last traded?

The last trade of ZyVersa Therapeutics, Inc. - Common Stock was at 07/16/25 04:00 PM ET

What is the market capitalization of ZyVersa Therapeutics, Inc. - Common Stock?

The market capitalization of ZyVersa Therapeutics, Inc. - Common Stock is 2.52M

How many shares of ZyVersa Therapeutics, Inc. - Common Stock are outstanding?

ZyVersa Therapeutics, Inc. - Common Stock has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.